BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 15221261)

  • 21. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study.
    Vignali C; Bargellini I; Grosso M; Passalacqua G; Maglione F; Pedrazzini F; Filauri P; Niola R; Cioni R; Petruzzi P
    AJR Am J Roentgenol; 2005 Aug; 185(2):472-80. PubMed ID: 16037523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis.
    Cejna M; Peck-Radosavljevic M; Thurnher SA; Hittmair K; Schoder M; Lammer J
    Radiology; 2001 Nov; 221(2):437-46. PubMed ID: 11687688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts.
    Bercu ZL; Fischman AM; Kim E; Nowakowski FS; Patel RS; Schiano TD; Chang CY; Lookstein RA
    AJR Am J Roentgenol; 2015 Mar; 204(3):654-61. PubMed ID: 25714299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations.
    Kim SK; Belikoff BG; Guevara CJ; Park SJ
    Dig Dis Sci; 2017 Feb; 62(2):305-318. PubMed ID: 28058594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.
    Schultheiss M; Bettinger D; Sturm L; Schmidt A; Backhus J; Waidmann O; Radecke K; Grandt D; Thimme R; Rössle M
    Cardiovasc Intervent Radiol; 2022 May; 45(5):542-549. PubMed ID: 35020042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of transjugular intrahepatic portosystemic shunt using 12 mm diameter polytetrafluoroethylene covered stents in cirrhotic patients with portal hypertension.
    Habash M; Murray A; Heeke B; Mahmoud K; Li Y; Saddekni S; Abdel Aal AK; Gunn AJ
    Diagn Interv Radiol; 2022 May; 28(3):239-243. PubMed ID: 35748206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

  • 32. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.
    Wang CM; Li X; Fu J; Luan JY; Li TR; Zhao J; Dong GX
    Chin Med J (Engl); 2016 Jun; 129(11):1261-7. PubMed ID: 27231160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
    Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Fan X; Li J
    Am Surg; 2013 Mar; 79(3):305-12. PubMed ID: 23461959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.
    Hidajat N; Vogl T; Stobbe H; Schmidt J; Wex C; Lenzen R; Berg T; Neuhaus P; Felix R
    Acta Radiol; 2000 Sep; 41(5):474-8. PubMed ID: 11016769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The transjugular intrahepatic portosystemic stent-shunt (TIPS) in the management of portal hypertension. A preliminary report].
    Aguilar Ramírez JR; Alcantara Peraza RA; Hernández Pérez RE; Gómez Maganda y Silva T; Heredia Jarero NM; Torres Valadez F; Gómez del Campo López A
    Rev Gastroenterol Mex; 1994; 59(3):218-22. PubMed ID: 7716362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Han J; Huang Q; Li N; Li J
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):701-8. PubMed ID: 20703849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes of transjugular intrahepatic portosystemic shunt with PTFE-covered stents after liver transplantation and technical results in split and whole liver graft recipients.
    Maruzzelli L; D'Amico M; Tuzzolino F; Petridis I; Gruttadauria S; Miraglia R; Luca A
    Eur Radiol; 2023 Apr; 33(4):2612-2619. PubMed ID: 36418620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.